APCOM and Asia Pacific Transgender Network (APTN) are part of a working group for a new regional survey exploring the values and preferences of PrEP products among men who have sex with men (MSM) and transgender women (TGW). The survey is a partnership between WHO, UNAIDS, FHI 360, PATH and IHRI and our research partners the Kirby Institute, UNSW and Monash University.
New long-acting PrEP products are becoming available (such as long-acting injectable cabotegravir) that will offer the community choice and have the potential to increase PrEP availability and uptake. We’re conducting the survey in 17 countries in Asia and the Pacific, including Thailand and Vietnam, to understand the values and preferences of key population communities. We intend for this to support improved PrEP programs and guidelines. It will also provide evidence to advocate for new products to be available for our communities. Ultimately, we hope this will support efforts to reduce new HIV infections.
Survey Link
HIV is a big health issue and access to PrEP, the powerful anti-HIV drug, is still limited in many countries across Asia. Community groups and health authorities want to improve PrEP availability for transgender women & men who have sex with men and we need your help. This survey is the first of its kind in Asia and the data will make a big difference in helping end the HIV epidemic. Spare 10-15 minutes of your time and participate in this anonymous survey for a good cause.
The survey is accessible through the links below. Kindly note that the survey is available in your local language(s) and these links are unique to Thailand and Vietnam.
Thai translation for MSM: Link
Thai translation for TGW: Link
Vietnam translation for MSM: Link
Vietnam translation for TGW: Link